Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Controlled human malaria infection with a clone of Plasmodium vivax with high quality genome assembly
Journal article
Minassian AM. et al, (2021), JCI Insight
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum
Journal article
Milne K. et al, (2021), eLife, 10
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Journal article
van Doremalen N. et al, (2021), Nature, 590, E24 - E24
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Journal article
van Doremalen N. et al, (2020), Nature, 586, 578 - 582
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
Journal article
van Doremalen N. et al, (2020), Science Advances, 6
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates
Journal article
Douglas AD. et al, (2019), Nature Communications, 10
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
Journal article
Rampling T. et al, (2018), npj Vaccines, 3
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Journal article
Payne RO. et al, (2017), JCI Insight, 2
SAFETY AND IMMUNOGENICITY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE CHAD63-MVA RH5 IN A PHASE IA CLINICAL TRIAL
Conference paper
Payne R. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 95, 313 - 313
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Journal article
Payne RO. et al, (2017), JCI Insight, 2
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
Journal article
Bliss CM. et al, (2017), Molecular Therapy, 25, 547 - 559
Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts
Journal article
Churcher TS. et al, (2017), PLOS Pathogens, 13, e1006108 - e1006108
HIGH LEVEL EFFICACY IN HUMANS OF A NEXT-GENERATION PLASMODIUM FALCIPARUM ANTI-SPOROZOITE VACCINE: R21 IN MATRIX-M (TM) ADJUVANT
Conference paper
Venkatraman N. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 97, 594 - 594
PROBABILITY OF TRANSMISSION OF MALARIA FROM MOSQUITO TO HUMAN IS REGULATED BY PARASITE DENSITY IN NAIVE AND VACCINATED HOSTS
Conference paper
Churcher TS. et al, (2017), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 97, 230 - 230
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal
Journal article
Mensah VA. et al, (2016), PLOS ONE, 11, e0167951 - e0167951
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
Journal article
Rampling T. et al, (2016), Journal of Infectious Diseases, 214, 772 - 781
Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Journal article
Payne RO. et al, (2016), Journal of Infectious Diseases, 213, 1743 - 1751